LMPPX
Price
$38.25
Change
-$0.08 (-0.21%)
Updated
Aug 15 closing price
Net Assets
9.51B
VTSAX
Price
$154.04
Change
-$0.41 (-0.27%)
Updated
Aug 15 closing price
Net Assets
1.91T
Interact to see
Advertisement

LMPPX vs VTSAX

Header iconLMPPX vs VTSAX Comparison
Open Charts LMPPX vs VTSAXBanner chart's image
ClearBridge Appreciation R
Price$38.25
Change-$0.08 (-0.21%)
VolumeN/A
Net Assets9.51B
Vanguard Total Stock Mkt Idx Adm
Price$154.04
Change-$0.41 (-0.27%)
VolumeN/A
Net Assets1.91T
LMPPX vs VTSAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LMPPX vs. VTSAX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMPPX is a Buy and VTSAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.91T vs. LMPPX (9.51B). VTSAX pays higher dividends than LMPPX: VTSAX (1.18) vs LMPPX (0.09). LMPPX was incepted earlier than VTSAX: LMPPX (19 years) vs VTSAX (25 years). LMPPX (1.24) is less costly to investors than VTSAX (0.04). LMPPX is a more actively managed with annual turnover of: 17.00 vs. VTSAX (2.00). LMPPX has a lower initial minimum investment than VTSAX: LMPPX (0) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 16.53 vs. LMPPX (7.41). VTSAX return over 5 years is better than : 86.35 vs. LMPPX (43.94).
LMPPXVTSAXLMPPX / VTSAX
Total Expense Ratio1.240.043,100%
Annual Report Gross Expense Ratio1.240.043,100%
Fund Existence19 years25 years-
Gain YTD10.3669.566108%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets9.51B1.91T0%
Annual Yield % from dividends0.091.188%
Returns for 1 year7.4116.5345%
Returns for 3 years23.8647.2151%
Returns for 5 years43.9486.3551%
Returns for 10 years88.04203.9843%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTGN3.310.36
+12.01%
VistaGen Therapeutics
RXRX5.770.13
+2.30%
Recursion Pharmaceuticals
FTV48.160.36
+0.75%
Fortive Corp
DSS0.83N/A
+0.39%
DSS
CBNK32.68-0.32
-0.97%
Capital Bancorp